logo
Longevity enthusiast Bryan Johnson says he doesn't want to run his anti-aging company anymore

Longevity enthusiast Bryan Johnson says he doesn't want to run his anti-aging company anymore

Bryan Johnson says he's considering winding up or selling his anti-aging startup, Blueprint.
Johnson was speaking to Wired's Katie Drummond in an interview published Monday, and he was asked about the conflicts that came with running his business and religion at the same time.
The 47-year-old biotech entrepreneur is best known for his aggressive quest for eternal youth. In 2021, Johnson embarked on his anti-aging program, Project Blueprint, which he says costs him $2 million a year.
At one point, Johnson infused himself with blood from his son to slow down his aging. He stopped the transfusions after six months, saying there were "no benefits detected."
Johnson's company sells a variety of wellness products. These include a $55 "longevity mix" drink and a $42 mushroom coffee alternative they call "Super Shrooms."
In March, Johnson announced on X that he was starting his own religion, "Don't Die." The name is derived from the slogan Johnson used to brand his Netflix documentary, products, and events.
"Years ago, I did a thought experiment imagining myself in the presence of people from the 25th century. It seemed obvious that they'd say Don't Die is how humanity saved itself and merged with AI," Johnson wrote in an X post.
Johnson, however, says he's beginning to see how running a longevity-focused business may not mesh with preaching a religion on the same subject.
"Honestly, I am so close to either shutting it down or selling it," he told Drummond, adding that he's "been talking to people about this."
"I don't need the money, and it's a pain-in-the-ass company," he said.
Johnson said he started the business because his friends were asking him for the health supplements he was taking.
"It just evolved in a way where I was trying to do people a solid. The problem is now people see the business and give me less credibility on the philosophy side," Johnson said.
"I will not make that trade-off. It is not worth it to me. So yeah, I don't want it," he added.
Earlier this year, The New York Times reported that Blueprint was facing problems with its finances. The story was published in March and was based on interviews with current and former employees as well as court records and internal documents.
The Times' said in its reporting that Blueprint was missing its break-even point by at least $1 million a month. It added that Johnson had told executives that Blueprint was running out of money.
Johnson told Wired that Blueprint isn't in "some kind of emergency financial situation."
"We are break-even, and I've said that publicly many times. We've had profitable months, we've had loss months," he added.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Netflix and Apple are backing away from great games
Netflix and Apple are backing away from great games

The Verge

timean hour ago

  • The Verge

Netflix and Apple are backing away from great games

For the last few years, subscription gaming services like Apple Arcade and Netflix have offered mobile game developers something of a haven for high-quality, premium mobile games: a type of game that had become vanishingly rare following the rise of the microtransaction-stuffed free-to-play model. But as these services' once enviable lineup of indie games dwindles, that haven appears to be shrinking. In 2021, Netflix announced a new gaming initiative, offering users a chance to play games through the streaming service's mobile app. Apple launched a similar program with Apple Arcade just two years before that. Both services offered an interesting value proposition: Pay a monthly subscription fee to get access to a library of premium games, with some of those games available as mobile exclusives. Those games would have no ads or in-app purchases, and the money paid to studios would ostensibly be used to fund the development of more games. The games themselves covered an interesting range of genres and topics, from strategy games featuring depression and dodgeball to finding one's place by literally rearranging the space around you. Netflix funding something like Harmonium: The Musical, a game about a Deaf girl's love of music, signaled that the platform was taking its gaming initiative seriously, bringing titles from off the beaten path to the platform. But now that game appears to have been pulled from Netflix's lineup. In addition to serving as a publisher, Netflix took the additional step of outright purchasing game studios like Oxenfree developer Night School Studio and Cozy Grove studio Spry Fox to make bespoke games for the service. But late last year, Netflix closed down the studio it spun up to produce what was going to be the service's first blockbuster AAA game. Then, just this month, it announced it was going to delist some of its most notable third-party titles, including indie darlings like Hades and the Monument Valley series. Netflix is increasingly focused on games tied to its own content. In its most recent quarterly earnings report, the platform briefly extolled its continued investment in titles like Squid Game: Unleashed and Thronglets — games tied to Netflix-produced Squid Game and Black Mirror, respectively. This focus, though, seems to come at the expense of adding existing original games from independent developers. It's easy to understand this shift. While these services don't share much about hard numbers, third-party reporting suggested that the majority of Netflix users never engaged with the platform's gaming offerings. And the games they were playing, in however limited amounts, were familiar titles. It's no surprise that GTA had Netflix's biggest game launch. At GDC 2025, Netflix's president of games, Alain Tascan, spoke to The Verge about the platform refocusing its gaming efforts, saying of indie games, 'We will continue supporting some of them, but I feel that indie gamers are not really coming to Netflix to find indie games.' So far Apple has only purchased a single game studio to make content for Apple Arcade, though its retreat to more casual offerings follows a similar pattern as Netflix. Original or indie games appear less frequently in favor of those attached to big, family-friendly IP like Uno, Angry Birds, and Bluey, all three of which are featured in Apple Arcade's July update. Payouts from Apple Arcade have reportedly been shrinking while developers have complained that it's hard to get their games noticed on the platform. The free-to-play model has conditioned users that spending money for gaming content can be optional. Casual games like Monopoly Go make money through in-game advertisements or opt-in consumer spending on microtransactions, and few traditional paid games outside of Minecraft are now able to break through that mindset. Subscription services were viewed as a kind of equalizer. With investment from Apple and Netflix and elsewhere, quality games could be brought to a platform not generally associated with quality gaming experiences. Developers could fund their vision and not have to worry about monetization, while consumers could access those games with a monthly subscription and no added costs. But a few years in, the aim of these services has been adjusted, and casual games designed to keep eyeballs on an app for as long as possible, or promote the latest streaming series, have won out. Despite strong lineups of indie games, neither Netflix nor Apple could really cut through the noise, and their offerings are no longer unique. Worse still, the unique games they did have now have fewer places to go. Posts from this author will be added to your daily email digest and your homepage feed. See All by Ash Parrish Posts from this topic will be added to your daily email digest and your homepage feed. See All Analysis Posts from this topic will be added to your daily email digest and your homepage feed. See All Apple Posts from this topic will be added to your daily email digest and your homepage feed. See All Entertainment Posts from this topic will be added to your daily email digest and your homepage feed. See All Gaming Posts from this topic will be added to your daily email digest and your homepage feed. See All Netflix Posts from this topic will be added to your daily email digest and your homepage feed. See All Streaming Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech

Jim Cramer on Johnson & Johnson: 'J&J is Just Beginning Its Move'
Jim Cramer on Johnson & Johnson: 'J&J is Just Beginning Its Move'

Yahoo

timean hour ago

  • Yahoo

Jim Cramer on Johnson & Johnson: 'J&J is Just Beginning Its Move'

Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shed light on. Cramer was incredibly bullish on the company as he said: 'Now, sometimes in this game, you do just get lucky. You'll come across a surprise quarter that tells you everything you need to know about what can cause a big cap stock to rally 10 points in a session. You'll see how a star is born and even get a blueprint for what you need, what you should be looking for. Yesterday, we got a beautiful schematic from none other than Johnson & Johnson… which handed you a 10-point victory for the ages… This company put on a clinic that showed you exactly how you can orchestrate such a big gain… What does it take? Surprises, many surprises, that's what… Trong Nguyen / Johnson & Johnson (NYSE:JNJ) develops, manufactures, and sells healthcare products, including prescription treatments across areas such as immunology, oncology, neuroscience, and cardiovascular disease, along with medical technologies used in surgery, orthopaedics, cardiovascular care, and vision correction. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Netflix Second Quarter 2025 Earnings: EPS Beats Expectations
Netflix Second Quarter 2025 Earnings: EPS Beats Expectations

Yahoo

time2 hours ago

  • Yahoo

Netflix Second Quarter 2025 Earnings: EPS Beats Expectations

Netflix (NASDAQ:NFLX) Second Quarter 2025 Results Key Financial Results Revenue: US$11.1b (up 16% from 2Q 2024). Net income: US$3.13b (up 46% from 2Q 2024). Profit margin: 28% (up from 23% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$7.35 (up from US$4.99 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Netflix EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.7%. Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Entertainment industry in the US. Performance of the American Entertainment industry. The company's shares are down 5.6% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Netflix's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store